Analysis of Efficacy of DICE (Dexamethasone, Ifosfamide, Cisplatin and Etoposide) Regimen on Recurrent and Refractory Intermediate and High Grade Non-Hodgkin's Lymphoma

Analysis of Efficacy of DICE (Dexamethasone, Ifosfamide, Cisplatin and Etoposide) Regimen on Recurrent and Refractory Intermediate and High Grade Non-Hodgkin's Lymphoma

OBJECTIVE Thus far there is no standard salvage regimen for patients with recurrent and refractory intermediate and high grade non-Hodgkin’s lymphoma (NHL). This study intends to investigate the therapeutic efficacy of the DICE (dexamethasone, isofosfamide, cisplatin and etoposide) regimen on the...

Full description

Bibliographic Details
Main Authors: Lei YANG, Zhucheng SONG, Xiaohong XU
Format: Article
Language:English
Published: China Anti-Cancer Association 2009-02-01
Series:Cancer Biology & Medicine
Subjects:
Non-Hodgkin’s lymphoma
chemotherapy
DICE regimen
therapeutic effect
adverse effect.
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/176

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/176

Similar Items